Key statistics
On Wednesday, HUTCHMED (China) Ltd (0J7G:LSE) closed at 15.69, 31.85% above the 52 week low of 11.90 set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 15.69 |
Low | 15.69 |
Bid | -- |
Offer | -- |
Previous close | 15.51 |
Average volume | 189.33 |
---|---|
Shares outstanding | 174.42m |
Free float | 88.83m |
P/E (TTM) | 71.29 |
Market cap | 2.67bn USD |
EPS (TTM) | 0.2162 USD |
Data delayed at least 15 minutes, as of Jul 02 2025 16:48 BST.
More ▼
- Blocklisting Six Monthly Return
- China Approval based on Phase III SACHI Trial
- Total Voting Rights
- HUTCHMED Announces China Approval for ORPATHYS® in Combination with TAGRISSO® for the Treatment of Lung Cancer Patients with MET Amplification After Progression on First-Line EGFR Inhibitor Therapy
- Grant of Share Options and Awards under LTIP
- HUTCHMED and Innovent Announce NDA Acceptance
- HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Renal Cell Carcinoma
- HUTCHMED Highlights SACHI Phase III Data at ASCO
- HUTCHMED Highlights SACHI Phase III Study Data Presented at the 2025 ASCO Annual Meeting
- Total Voting Rights
More ▼